CALIX INC (CALX)

US13100M5094 - Common Stock

35.36  +0.69 (+1.99%)

After market: 35.36 0 (0%)

Fundamental Rating

4

CALX gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 51 industry peers in the Communications Equipment industry. CALX has an excellent financial health rating, but there are some minor concerns on its profitability. CALX has a expensive valuation and it also scores bad on growth.



4

1. Profitability

1.1 Basic Checks

CALX had positive earnings in the past year.
In the past year CALX had a positive cash flow from operations.
CALX had positive earnings in 4 of the past 5 years.
CALX had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

With a decent Return On Assets value of -1.96%, CALX is doing good in the industry, outperforming 60.78% of the companies in the same industry.
With a decent Return On Equity value of -2.37%, CALX is doing good in the industry, outperforming 60.78% of the companies in the same industry.
Industry RankSector Rank
ROA -1.96%
ROE -2.37%
ROIC N/A
ROA(3y)13.29%
ROA(5y)8.42%
ROE(3y)17.35%
ROE(5y)10.5%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

CALX's Profit Margin has declined in the last couple of years.
In the last couple of years the Operating Margin of CALX has declined.
The Gross Margin of CALX (50.94%) is better than 68.63% of its industry peers.
CALX's Gross Margin has improved in the last couple of years.
CALX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 50.94%
OM growth 3Y-32.39%
OM growth 5YN/A
PM growth 3Y-23.05%
PM growth 5YN/A
GM growth 3Y0.35%
GM growth 5Y2.19%

9

2. Health

2.1 Basic Checks

CALX does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CALX has less shares outstanding
CALX has more shares outstanding than it did 5 years ago.
There is no outstanding debt for CALX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

An Altman-Z score of 9.71 indicates that CALX is not in any danger for bankruptcy at the moment.
The Altman-Z score of CALX (9.71) is better than 94.12% of its industry peers.
CALX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 9.71
ROIC/WACCN/A
WACC9.8%

2.3 Liquidity

CALX has a Current Ratio of 4.50. This indicates that CALX is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of CALX (4.50) is better than 86.27% of its industry peers.
CALX has a Quick Ratio of 3.73. This indicates that CALX is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of CALX (3.73) is better than 90.20% of its industry peers.
Industry RankSector Rank
Current Ratio 4.5
Quick Ratio 3.73

2

3. Growth

3.1 Past

The earnings per share for CALX have decreased strongly by -41.10% in the last year.
Measured over the past years, CALX shows a quite strong growth in Earnings Per Share. The EPS has been growing by 17.73% on average per year.
CALX shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -12.68%.
The Revenue has been growing by 18.69% on average over the past years. This is quite good.
EPS 1Y (TTM)-41.1%
EPS 3Y17.73%
EPS 5YN/A
EPS Q2Q%-71.11%
Revenue 1Y (TTM)-12.68%
Revenue growth 3Y24.31%
Revenue growth 5Y18.69%
Sales Q2Q%-23.84%

3.2 Future

Based on estimates for the next years, CALX will show a decrease in Earnings Per Share. The EPS will decrease by -4.63% on average per year.
CALX is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -2.20% yearly.
EPS Next Y-66.72%
EPS Next 2Y-32.85%
EPS Next 3Y-4.63%
EPS Next 5YN/A
Revenue Next Year-20.18%
Revenue Next 2Y-9.27%
Revenue Next 3Y-2.2%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

1

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 41.12, the valuation of CALX can be described as expensive.
Based on the Price/Earnings ratio, CALX is valued a bit cheaper than 60.78% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.73. CALX is valued slightly more expensive when compared to this.
With a Price/Forward Earnings ratio of 50.60, CALX can be considered very expensive at the moment.
CALX's Price/Forward Earnings ratio is in line with the industry average.
CALX is valuated expensively when we compare the Price/Forward Earnings ratio to 22.83, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 41.12
Fwd PE 50.6

4.2 Price Multiples

CALX's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 45.91
EV/EBITDA N/A

4.3 Compensation for Growth

CALX's earnings are expected to decrease with -4.63% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-32.85%
EPS Next 3Y-4.63%

0

5. Dividend

5.1 Amount

CALX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CALIX INC

NYSE:CALX (12/20/2024, 7:02:26 PM)

After market: 35.36 0 (0%)

35.36

+0.69 (+1.99%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryCommunications Equipment
Earnings (Last)10-28 2024-10-28/amc
Earnings (Next)01-27 2025-01-27/amc
Inst Owners90.48%
Inst Owner Change-1.02%
Ins Owners10.22%
Ins Owner Change-0.35%
Market Cap2.35B
Analysts78.46
Price Target45.73 (29.33%)
Short Float %4.44%
Short Ratio3.46
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)39.32%
Min EPS beat(2)37.25%
Max EPS beat(2)41.39%
EPS beat(4)3
Avg EPS beat(4)21.83%
Min EPS beat(4)-7.62%
Max EPS beat(4)41.39%
EPS beat(8)7
Avg EPS beat(8)20.51%
EPS beat(12)11
Avg EPS beat(12)20.24%
EPS beat(16)15
Avg EPS beat(16)27.18%
Revenue beat(2)0
Avg Revenue beat(2)-2.64%
Min Revenue beat(2)-3.27%
Max Revenue beat(2)-2.02%
Revenue beat(4)0
Avg Revenue beat(4)-3.04%
Min Revenue beat(4)-5.05%
Max Revenue beat(4)-1.83%
Revenue beat(8)0
Avg Revenue beat(8)-1.9%
Revenue beat(12)3
Avg Revenue beat(12)-0.41%
Revenue beat(16)7
Avg Revenue beat(16)0.53%
PT rev (1m)3.07%
PT rev (3m)3.07%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-54.87%
EPS NY rev (1m)0%
EPS NY rev (3m)4.27%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-6.3%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.1%
Valuation
Industry RankSector Rank
PE 41.12
Fwd PE 50.6
P/S 2.63
P/FCF 45.91
P/OCF 34.51
P/B 3.01
P/tB 3.54
EV/EBITDA N/A
EPS(TTM)0.86
EY2.43%
EPS(NY)0.7
Fwd EY1.98%
FCF(TTM)0.77
FCFY2.18%
OCF(TTM)1.02
OCFY2.9%
SpS13.42
BVpS11.74
TBVpS9.99
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.96%
ROE -2.37%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 50.94%
FCFM 5.74%
ROA(3y)13.29%
ROA(5y)8.42%
ROE(3y)17.35%
ROE(5y)10.5%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)7.54%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-32.39%
OM growth 5YN/A
PM growth 3Y-23.05%
PM growth 5YN/A
GM growth 3Y0.35%
GM growth 5Y2.19%
F-Score5
Asset Turnover0.95
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 87.65%
Cap/Sales 1.9%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.5
Quick Ratio 3.73
Altman-Z 9.71
F-Score5
WACC9.8%
ROIC/WACCN/A
Cap/Depr(3y)91.78%
Cap/Depr(5y)92.34%
Cap/Sales(3y)1.63%
Cap/Sales(5y)1.89%
Profit Quality(3y)60.78%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-41.1%
EPS 3Y17.73%
EPS 5YN/A
EPS Q2Q%-71.11%
EPS Next Y-66.72%
EPS Next 2Y-32.85%
EPS Next 3Y-4.63%
EPS Next 5YN/A
Revenue 1Y (TTM)-12.68%
Revenue growth 3Y24.31%
Revenue growth 5Y18.69%
Sales Q2Q%-23.84%
Revenue Next Year-20.18%
Revenue Next 2Y-9.27%
Revenue Next 3Y-2.2%
Revenue Next 5YN/A
EBIT growth 1Y-171.71%
EBIT growth 3Y-15.96%
EBIT growth 5YN/A
EBIT Next Year-58.82%
EBIT Next 3Y4.54%
EBIT Next 5YN/A
FCF growth 1Y140.46%
FCF growth 3Y-4.14%
FCF growth 5YN/A
OCF growth 1Y101.69%
OCF growth 3Y3.05%
OCF growth 5Y73.67%